Carrier-Free Nanoplatform via Evoking Pyroptosis and Immune Response against Breast Cancer

Author:

Li Lei1,Tian Hailong2,Zhang Zhe2,Ding Ning1,He Kai1,Lu Shuaijun3,Liu Ruolan1,Wu Peijie1,Wang Yu2,He Bo2,Luo Maochao2,Peng Peilan2,Yang Mao4,Nice Edouard C.5ORCID,Huang Canhua12,Xie Na2,Wang Dong1,Gao Wei6ORCID

Affiliation:

1. School of Basic Medical Sciences and State Key Laboratory of Southwestern Chinese Medicine Resources, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China

2. State Key Laboratory of Biotherapy and Cancer Center, West China Hospital and West China School of Basic Medical Sciences and Forensic Medicine, Sichuan University and Collaborative Innovation Center for Biotherapy, Chengdu 610041, China

3. The Affiliated Hospital of Ningbo University School of Medicine, Ningbo 315020, China

4. Institute for Cancer Medicine and School of Basic Medical Sciences, Southwest Medical University, Luzhou, Sichuan 646000, China

5. Department of Biochemistry and Molecular Biology, Monash University, Clayton, VIC 3800, Australia

6. Clinical Genetics Laboratory, Affiliated Hospital & Clinical Medical College of Chengdu University, Chengdu 610081, China

Funder

Ministry of Science and Technology of the People's Republic of China

National Natural Science Foundation of China

Guangdong Basic and Applied Basic Research Foundation

1?3?5 project for disciplines of excellence

Publisher

American Chemical Society (ACS)

Subject

General Materials Science

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3